PT - JOURNAL ARTICLE AU - Baptiste Elie AU - Emmanuel Lecorche AU - Mircea T. Sofonea AU - Sabine Trombert-Paolantoni AU - Vincent Foulongne AU - Jérémie Guedj AU - Stpéhanie Haim-Boukobza AU - Bénédicte Roquebert AU - Samuel Alizon TI - Inferring SARS-CoV-2 variant within-host kinetics AID - 10.1101/2021.05.26.21257835 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.26.21257835 4099 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257835.short 4100 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257835.full AB - SARS-CoV-2 variants are causing epidemic rebounds in many countries. By analyzing longitudinal cycle threshold (Ct) values from screening tests in the general population and hospitals, we find that infections caused by variant lineages have higher peak viral load than wild type lineages and, for the B.1.1.7 lineage, have a longer infectious period duration. Linking within-host kinetics to transmission data suggests that infections caused by variants have higher transmission potentials and that their epidemiological fitness may depend on the demography of the host population.Competing Interest StatementJG has worked as a consultant for ROCHE Company.Clinical TrialNCT04653844Funding StatementBE is funded by the Ministere de l'Enseignement Superieur et de la RechercheAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the CHU of MontpellierAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available online on a gitlab repository